Followers | 289 |
Posts | 22370 |
Boards Moderated | 1 |
Alias Born | 01/30/2007 |
Thursday, May 26, 2022 7:16:13 AM
On May 25, 2022, Clover Health Investments, Corp. (the “Company”) announced that Scott J. Leffler will become Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer, effective upon the commencement of his employment with the Company in August 2022. Mr. Leffler will succeed Mark C. Herbers, the Company’s current Interim Chief Financial Officer, who will continue in his role as Interim Chief Financial Officer until Mr. Leffler joins the Company and thereafter will assist in the transition. The Company’s press release announcing Mr. Leffler’s appointment is attached to this report as Exhibit 99.1 and is incorporated by reference into this Item 5.02.
Recent CLOV News
- Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/23/2024 08:05:00 PM
- Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer • GlobeNewswire Inc. • 04/22/2024 08:05:00 PM
- Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions • GlobeNewswire Inc. • 04/04/2024 08:30:00 PM
- Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness • GlobeNewswire Inc. • 03/19/2024 01:00:00 PM
- Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Global Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market Trading • IH Market News • 03/12/2024 11:22:57 AM
- Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/16/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:41:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:25:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 08:51:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 09:10:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:21:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 01:31:57 PM
- Clover Health Provides Business Update and Full-Year 2024 Objectives • GlobeNewswire Inc. • 01/10/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:03:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:02:24 PM
- PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent • GlobeNewswire Inc. • 01/08/2024 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:30:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:26:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:16:30 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM